Daniel Stasiewicz MSc

Daniel Stasiewicz, MSc, MBA, is a Global Clinical Operations Leader with over 18 years of experience in the field of hematology and oncology. They have held positions such as Global Study Director for early development hematology CAR-T trials at AstraZeneca and Senior Clinical Trial Manager at Johnson & Johnson, where they oversaw multiple phase III studies in multiple myeloma. Daniel's expertise includes driving complex clinical programs from early to late development, as well as innovating clinical delivery models to accelerate drug development. They hold a Master of Science in Molecular Biology from the University of Gdansk and an MBA from Apsley Business School, along with post-graduate studies in Project Management from the Warsaw School of Economics.